An Open Label, Single Treatment, Single Arm, Multiple Dose Phase-2 Study to Evaluate the Pharmacokinetics, Safety, and Clinical Performance of EscharEx (EX-03) in Participants With Venous Leg Ulcers

Clinical trial NCT07692178 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07692178
Sponsor: MediWound Ltd
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Venous Leg Ulcer (VLU)

Start date: 2026-08-01
Primary completion: 2028-08-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.